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At a glance commentary Scientific Knowledge on the Subject
• TB disease during pregnancy has adverse effects on mother and child.
• Risks of TB far outweigh the risk of TB treatment during pregnancy • Current evidence of TB incidence in pregnancy is inconclusive, but local studies indicated a potentially high TB incidence during pregnancy.
What this study adds to the Field • The study found a significantly increased incidence of TB diagnosis in mothers postpartum which probably reflects an increase in TB incidence during pregnancy.
• The self-controlled case series found an increased TB risk post-partum, adjusting for individual confounders. Tuberculosis (TB) disease adversely affects mother and child, and strategies to control TB in this group are important. The aim of this study was to analyse the epidemiology of TB in pregnancy, and establish whether pregnancy is an independent risk factor for TB.
Methods
The UK-wide cohort study was based on the General Practitioner Research Database (GPRD), enrolling all women with pregnancies between 1996 and 2008. Incidence rates (IR) and ratios (IRR) of TB events during pregnancy, 6 months post-partum, and outside pregnancy were calculated and compared using Poisson regression. A nested self-controlled case series (SCCS) compared the risk of TB in these periods, adjusting for individual and time-bound confounders.
Results
The crude TB rate for the combined pregnancy and post-partum period was 15.4 per 100,000 person years (py), significantly higher than outside of pregnancy (9.1 per 100,000 py, p=0.02). Adjusting for age, region and socio-economic status the post-partum TB risk was significantly higher than outside pregnancy (IRR 1.95, CI 1.24-3.07), whereas there was no significant increase during pregnancy (IRR 1.29, CI 0.82-2.03). These observations were confirmed in the SCCS (IRR 1.62, CI 1.01-2.58 and 1.03, CI 0.64-1.65 respectively). 
Conclusions
The incidence of TB diagnosis is significantly increased post-partum. Although we did not find an increase during pregnancy, the post-partum incidence may reflect an increase during pregnancy given diagnostic, immunological and administrative delays. Clinicians' awareness should be improved and the effectiveness of public health policy measures such as targeted screening of pregnant and post-partum women in high-risk groups should be evaluated. In the United Kingdom, recent rises in TB incidence have been associated with a change in the epidemiology of TB 4 with the disease now affecting younger age groups 3 and immigrants from high prevalence countries [4] [5] [6] . TB rates in pregnant women are expected to be higher because of the different demographic composition of this group 3 , and the fact that women from high prevalence areas often have a higher total period fertility rate 7 . Two local studies from large London teaching hospitals provided incidence estimates in pregnant women between 3-5 times higher than the respective local background rate (153 to 252 per 100,000 maternities) 8;9 . It, however, remains unclear whether pregnancy increases the risk of TB or if this observation relates to the higher occurrence of the disease in high-risk groups.
Pulmonary 10 as well as extra-pulmonary TB 11 adversely affect the health of mother and child.
TB in pregnancy has been shown to respond to standard treatment 9 , but considerable delays in diagnosis have been observed amongst these women 9 , and delays in treatment initiation are associated with poorer outcomes for mother and foetus 10 . A possible intervention to avoid these adverse outcomes will be to promote active case finding for TB in pregnant
women. This will, however, only be appropriate if pregnancy itself increases the risk of TB. In to active TB only 12 . However, literature from elsewhere has promoted the screening of the wider pregnant population 13 .
There is currently insufficient evidence on the epidemiology of TB in pregnancy globally, and no data on whether pregnancy increases the risk of TB. The UK General Practice Research Database (GPRD) provided a suitable cohort to investigate the epidemiology of TB in pregnancy in the UK and determine whether TB is an independent risk factor for TB in order to inform future public health and screening policy. Some of the results of the study have been previously reported in the form of an abstract 14 
Methodology
We estimated incidence rates for TB in pregnancy, six months postpartum and outside of pregnancy, modelled adjusted incidence rate ratios in a retrospective cohort study and performed a nested self-controlled case series (SCCS) analysis, which adjusts for all non time-dependent confounders (see analysis and figure 1). These definitions were operationalised by choosing the respective Read codes from the database (TB events). We used the recording date for the TB diagnosis as our best estimate for the onset of TB disease. We counted repeated TB codes as new episodes if they were entered more than 12 months after the initial event 6 . This rule excludes new episodes in women, who are currently on TB treatment. Socio-economic status was measured using the UK index of multiple deprivations, a composite indicator based on employment, wealth and assets in a small area and events were censored at the end of practice registration (including death), last collection date for the practice, transfer-out date from the practice, or reaching the age of 50, whichever came first.
The database was cleaned and cross-checked. Other information from the individual's record, such as birth outcome, birth year, other pregnancies, death date or practice transfers were used to validate pregnancy and TB dates. The GPRD helped cross-checking death data against UK death records. Pregnancies with identical start or end dates were removed as duplicates.
Data analysis

Estimation of incidence
The crude incidence rate of TB disease in the cohort overall, during pregnancy, in the immediate post-pregnancy period and outside of pregnancy were calculated as the number of TB events per person-time at risk. The countrywide estimate was also weighted for different population sizes across UK regions.
We compared the incidence rates (IR) in pregnancy and post-partum with the rate outside of pregnancy, calculating IR ratios. A Poisson regression model was built, allowing the effect of these three strata to be adjusted for confounding factors. Each was added stepwise to the model and retained, if it changed the IR rates for the strata and a likelihood ratio test was significant (p<0.05), indicating the model with confounder explains the data better than the The self-controlled case series
In order to determine whether pregnancy is an independent risk factor for TB we performed a nested SCCS. This method, which has been validated elsewhere 17;18 , only includes individuals who have an event and exposure (n=177, figure 1). It compares the incidence of the event (i.e. TB) during exposure time to the respective incidence in a "control time" (i.e.
comparing incidence in the same person during a risk period with a non-risk period). The exposure times in this study are times during pregnancy and the six months following pregnancy, and control times all other person times before and after pregnancy (figure 1).
The method implicitly controls for all non time-dependent confounders of TB, such as country of origin or ethnicity. Age and period were adjusted for by including these variables in the model. The model was fitted using conditional Poisson regression and has similar statistical power compared with cohort studies 17 .
We carried out a sensitivity analysis by excluding the 6 months before each pregnancy from calculating the background risk as per protocol and in keeping with the literature 8 . This is because there is a theoretical possibility that women with worse health (e.g. unrecognised TB) are less willing to conceive, hence artificially lowering the pregnancy rate during this period. All data analysis was carried out using STATA 11.1. For the incidence study we estimated that about 35,000 person years or 50,000 pregnancies would be needed to detect the threefold higher TB incidence rate in pregnancy seen in some local studies 8;9 with 80% power and 5% significance, assuming a UK background rate of 13 per 100,000.
For the SCCS we estimated that 25 exposure-time events and 150 control-time events would be sufficient to detect a risk ratio of 1.7, whereas 100 and 700 events would allow detecting a risk ratio of 1.33 with 80% power at a 5% significance level.
Results
A total of 192,801 women with a total of 264,136 pregnancies (1-14 per woman) were included in the cohort study. Of the 516,589 women with pregnancies in the GPRD, about 271,625 (52.6%) were excluded, because their pregnancies were outside of the 12-year observation period and a further 52,163 (10.1%), because pregnancy dates could not be accurately determined from their records. Table 1 shows that the geographical and age distribution of included women is similar to all pregnancies ever reported to the GPRD.
Please insert here The mean age at pregnancy was 29.5 years (range 13-50). The mean age for cohort entry was 25.6 years (range 13-48.9) and cohort exit 35.1 years (range 13.7-50). The median length of pregnancy was 39.6 weeks (range 2-45), and two peaks of gestational length were observed, a smaller at 10.6 and a larger at 39.9 weeks. Most pregnancies resulted in a not further specified birth (79%), a miscarriage (9.1%), a caesarean section (6.2%), or an assisted (e.g. instrumental) delivery (5.2%). There were 405 records (0.15%) of neonatal deaths.
A total of 177 TB events were identified in the cohort, 22 of these occurring during pregnancy (8, 7 and 7 in the first, second and third trimester respectively) and 22 in the 180 days after pregnancy. The mean age at TB diagnosis was 30.1 years (range 13.4-44). None of the women had more than one TB episode. Most TB events were recorded in London (31%), followed by the Midlands (25%), North England (20%), South England (16%) and Scotland, Wales and Northern Ireland (9%).
61.6% of the TB events were not further specified. Amongst the remainder, extra-pulmonary TB (n=43) was more frequent than pulmonary TB (n=25). This seemed more pronounced in the TB events during or 180 days after pregnancy, where extra-pulmonary TB was found in Only one patient with a TB event in the cohort died and was censored 7 years after her pulmonary TB was diagnosed (outside pregnancy); it is improbable that the death was related to the TB.
The cohort study
The overall crude incidence rate of TB diagnosis was 10.1 (CI 8. 
Discussion
This is first primary care based cohort study, which quantifies the risk of TB during pregnancy and postpartum. We found a significantly increased risk in the six months following the pregnancy, but not during pregnancy. Considering diagnostic, administrative and immunological delays, TB risk during pregnancy is almost certainly also increased. The risk This study benefits from using a very large, representative and well maintained primary care database 15 , but remains an observational study based on data recorded for clinical purposes.
Our overall TB incidence rate was slightly lower than current UK TB rates 4 however these subject characteristics were adjusted for by design in the nested SCCS. The debate about an association between TB and pregnancy is unresolved 21 , although early studies failed to demonstrate a clear association 22 . Internationally there are no recent incidence estimates in non-HIV infected pregnant populations. A previous UK-wide study of TB in pregnancy based on an obstetric card return scheme 20 (4.2 per 100,000) may have underestimated incidence 23 , because additional case finding was limited and it was restricted to obstetricians, who do not normally see miscarriages. Comparatively 8;9 low extra-pulmonary TB rates in this study 20 , suggested an under-ascertainment of clinically less obvious cases. Our incidence estimates were lower than previous estimates from high risk areas within London 8;9 , explainable by the different setting in our study. Complex maternal immune system changes during pregnancy prevent allograft rejection of the foetus. One mechanism is the partial inhibition of the cellular immune system via cytokines (e.g. IL-10, TGF-β) 24 ;25 through an increase of specific T regulatory cell populations.
The susceptibility for specific infections such as influenza can increase during pregnancy 26 .
Mycobacteria cause a predominantly cellular immune response and recent studies found an up-regulation of specific T-cell inhibiting cytokines (IL-10, TGF-β) during TB reactivation 27 .
The physiological down-regulation of the cellular immune system is one possible explanation of the higher incidence rates of TB during and immediately after pregnancy.
The significantly increased risk in the 6 month postpartum period may reflect a delay between pregnancy and risk increase for TB. Likely explanations fall into three categoriesadministrative, immunological and medical. Since we took the first recorded TB date on the GPRD as event date, an administrative delay between diagnosis and recording of TB disease is possible. It is also likely that immunological changes gradually increase TB susceptibility during pregnancy as the expression of T-regulator cells are partially oestrogen-dependent 25 and increasing throughout the pregnancy 25;28 . After delivery, these changes gradually normalise again. Diagnostic delays have been described elsewhere 8;9 , despite the high level of access to healthcare enjoyed by pregnant women. Late presentations 8;9 , an ambiguity of symptoms, frequently mimicking physiological pregnancy changes 29 and a conservative approach to investigations (e.g. X-rays) have been blamed for these delays 30 . Delays in treatment initiation are associated with poorer outcomes for mother and foetus 10;19 and can be more pronounced in women of minority ethnic background or those who recently arrived from high prevalence areas 31 . These delays present a limitation to this study, and the combination of these delays is a possible reason for the failure to demonstrate a significant TB risk during pregnancy and the anticipation of these prompted us to propose an analysis of the six months post-pregnancy in our protocol.
In conclusion we found that there was an increased incidence of TB diagnosis in mothers postpartum which probably reflects an increase in TB incidence during pregnancy, given the diagnostic, immunological and administrative delays described above. About 25% of all events occurred during pregnancy and the postpartum (16% of total person time). To avoid adverse outcomes for mother and child it is vital to recognise and treat TB in pregnancy early 9-11;19 making diagnostic delays unacceptable. This suggests that further research is needed on the cost effectiveness of active case finding for TB in pregnant women. Research from Zimbabwe 32 found that untargeted active case finding in a high TB incidence area may be an effective tool for increasing case detection and the role of simple and cheap interventions such as sputum smears during antenatal care should be evaluated in high TB incidence countries. Replication of our observations in cohort studies from TB high burden countries may provide support for such an approach. In low incidence countries clinicians should have an elevated index of suspicion for TB during the pregnant and postpartum period, aiming to exclude this diagnosis particularly in those from high incidence countries.
Our results may prompt a rethink of current TB prevention strategies and increase clinical awareness of TB during pregnancy and the postpartum period. 
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